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Abstract—Endovascular stents are widely used for the
treatment of peripheral arterial disease (PAD). However,
the development of in-stent restenosis and downstream PAD
progression remain a challenge. Stent revascularisation of
PAD causes arterial trauma and introduces abnormal
haemodynamics, which initiate complicated biological pro-
cesses detrimental to the arterial wall. The interaction
between stent struts and arterial cells in contact, and the
blood ﬂow ﬁeld created in a stented region, are highly
affected by stent design. Spiral ﬂow is known as a normal
physiologic characteristic of arterial circulation and is
believed to prevent the development of ﬂow disturbances.
This secondary ﬂow motion is lost in atheromatous disease
and its re-introduction after endovascular treatment of PAD
has been suggested as a method to induce stabilised and
coherent haemodynamics. Stent designs able to generate
spiral ﬂow may support endothelial function and therefore
increase patency rates. This review is focused on secondary
ﬂow phenomena in arteries and the development of ﬂow
modiﬁcation stent technologies for the treatment of PAD.
Keywords—Peripheral arterial disease, Endovascular,
Restenosis, Wall shear stress, Spiral ﬂow, Helical ﬂow, Stent
design, Flow modiﬁcation, Helical stent, Spiral ﬂow stent,
Flow optimisation.
INTRODUCTION
Peripheral arterial disease (PAD) is recognised as an
independent risk factor for both myocardial and
cerebrovascular events which are the leading causes of
mortality worldwide. PAD can seriously impair the
quality of patients’ lives and can lead to leg ulceration,
gangrene and eventually amputation. It is the result of
any disease that can lead to impaired blood supply, of
which atherosclerosis is the main aetiology.1,62,80
Current clinical practice has shown an increased use of
stents as a treatment for PAD. The global PAD stent
market is expected to rise from $2.2bn in 2012 to
$3.6bn in 2019.27
There are three main arterial sites where stents are
used for PAD; iliac (pelvis), femoropopliteal (thigh)
and infrapopliteal (calf). The iliac and femoropopliteal
are the sites most commonly stented. Currently, the
majority of peripheral vascular stents used at these
sites are the bare metal stents most of which are made
from nitinol (nickel titanium shape memory alloy). The
use of covered stents is the second most common op-
tion, followed by drug-eluting and bioabsorbable
stents which are expected to be used more in the
future.27 Poor patency rates of stents for PAD remain
a challenge and vary in relation to severity of the dis-
ease and its location. In general, proximal infrain-
guinal stented locations provide better patency rates
than distal infrainguinal locations. Stents for PAD are
associated with increased rates of fracture because of
arterial compression, torsion, bending and contraction
in lower extremities.1,18,49,62
Stent implantation causes arterial structural injury,
introduces a foreign body and aﬀects the local
haemodynamics. The result is the activation of four
biological responses; thrombosis, neo-intimal hyper-
plasia (NIH), inﬂammation and re-endothelialisation.
These responses can cause re-narrowing of the stented
region, which is known as in-stent restenosis, or acti-
vate the development of PAD downstream from the
Address correspondence to Nicolas Aristokleous, Division of
Cardiovascular and Diabetes Medicine, Ninewells Hospital and
Medical School,University ofDundee,Mail Box 1,DundeeDD19SY,
United Kingdom. Electronic mail: n.aristokleous@dundee.ac.uk
Annals of Biomedical Engineering, Vol. 44, No. 2, February 2016 ( 2015) pp. 466–476
DOI: 10.1007/s10439-015-1483-4
0090-6964/16/0200-0466/0  2015 The Author(s). This article is published with open access at Springerlink.com
466
treated region.59 Furthermore in relation to local
haemodynamics, stents in infrainguinal arteries do not
support the re-introduction and propagation of the
physiologic rotational secondary ﬂow motions which
may affect their long term clinical results.
The aim of this paper is to review the arterial
haemodynamics and particularly the nature of sec-
ondary ﬂow motions in the arterial system. In addition,
to present the eﬀects of stent design in local haemo-
dynamics and review the current state of ﬂow modiﬁ-
cation technologies for the treatment of PAD.
ARTERIAL HAEMODYNAMICS
The haemodynamics of arterial blood ﬂow describes
the mechanical properties and the interactions between
blood ﬂow, vascular wall and perivascular tissue. More
speciﬁcally, haemodynamics describe the kinematics and
dynamics of bloodﬂowand obey the laws that govern the
mass and momentum of ﬂuid elements. The ﬁrst requires
the mass to be conserved (continuity), and the second
based on Newton’s law of motion, requires the conser-
vation of momentum (Navier–Stokes equations).
Computational ﬂuid dynamics (CFD) is widely used
to study the cardiovascular system based on image-
based patient speciﬁc techniques.2 Such CFD applica-
tions can be used in diagnosis, therapeutic planning
and post-operative monitoring of patients, supporting
the clinical decision making process. CFD may also be
used in the prediction of medical device performance.14
The blood vessels have the ability to respond to
haemodynamic stimuli, including the stretch and shear
stress resulting from ﬂow and circulatory (transmural)
pressure. This ability is mainly mediated by vascular
endothelial cells, which are in direct contact with blood
ﬂow. Endothelial cells can sense and respond to
hemodynamic stresses that are exerted upon them by
activating mechano-sensors, signalling pathways, and
gene and protein expressions.12
Wall shear stress (WSS) in a vessel is the tangential
force generated by blood ﬂow. WSS is determined as
the product of wall shear rate (WSR) and blood vis-
cosity, where WSR is the spatial gradient of blood
velocity normal to the wall.5 Two main theories have
been reported about the role of WSS in the develop-
ment of atherosclerosis. The ﬁrst suggests that
atherosclerosis may be developed in regions of high
WSS. In 1968, Fry26 supported this theory showing
that exposure of endothelial cells in shear stress above
379 ± 85 dynes cm22 for an hour resulted in cell
swelling, deformation disintegration and ﬁnally cell
dissolution and erosion. The second theory, which is
widely accepted today, denotes that early atheroma
coincides with the regions in which arterial WSR is
expected to be relatively low.5,8,9 Endothelial cells tend
to align in the blood ﬂow direction under physiologic
WSS conditions (>15 dynes cm22) inducing endothe-
lial quiescence; however, under low WSS (<4 dy-
nes cm22), which is prevalent at atherosclerosis-prone
sites, endothelial cells show no speciﬁc alignment.54
Despite the systemic nature of its associated risk
factors, atherosclerosis is a geometrically focal disease
and arises in complex regions such as bifurcations,
where disturbed ﬂow ﬁelds may be developed. Dis-
turbed ﬂow includes ﬂow recirculation and separation,
complex ﬂow patterns, non-uniform WSS distribution
containing regions of low and high mean WSS, long
particle residence times and stagnation.13,59 Flow stag-
nation drastically reduces the arterial WSS and leads the
endothelium to down-regulate the release of anti-
thrombotic agents and up-regulate the expression of
pro-coagulant agents. In general, disturbed ﬂow may
cause platelet activation and therefore increase platelet
adhesion which is involved in development of NIH and
thrombosis.3,56,75 For instance, studies in human vessel
branches and bifurcations have shown that lesions are
more likely to form along the outer wall of the branch
or bifurcation, where WSS is relatively low or oscillating
and ﬂow recirculation is observed.25,32,48,54
SECONDARY FLOW MOTIONS IN ARTERIES
During the last few decades it has been well presented
that blood ﬂow in medium and large size arteries is
spiral. The existence of secondary ﬂow motions in
arteries is related to both the physiological function and
anatomical structure of the cardiovascular system.
Heart
The heart is a remarkable structure that displays a
helical, transmural and overlapping pattern of
myocardial ﬁbres.43 The helical structure of myo-
cardium is related with the twisting heart motion
during systole and early diastole.4,43,73 A magnetic
resonance imaging (MRI) study by Jung et al.40
showed that during the spiral-compressive heart func-
tion the myocardium follows a helical descent motion.
The twisting motion during contraction and early
dilation generates a spiral blood pattern in the
ascending aorta,42,72 that may provide more efﬁcient
cardiac emptying and reduce the myocardium effort.67
Aorta
The existence of secondary ﬂow motions in the
ascending aorta was presented in 1987 by Segadal and
Matre64 with a transluminal Doppler ultrasound
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probe. Three years later Frazin et al.23 used colour
Doppler ultrasound to show rotational ﬂow in an
aortic arch model and human descending thoracic
aorta. Their main ﬁndings were a clockwise systolic
rotation and a counter-clockwise diastolic rotation. On
a post hoc study, they presented spiral ﬂow in the
abdominal aorta beyond the renal arteries.24 More
recently, spiral ﬂow was conﬁrmed in the ascending
and abdominal aortas using vector Doppler.63,72
The development of phase contrast MRI veriﬁed
clockwise helical ﬂow in the aortic arch and abdominal
aorta of healthy volunteers during systole and showed
a second retrograde rotational ﬂow along the inner
wall at end systole.34,35,42,55
Peripheral Arteries
Ku and Giddens,47 and Karino et al.41 showed the
development of secondary ﬂow motions in realistic
peripheral arterial models as a result of bifurcations
and branching. Complicated vortical structures were
associated with ﬂow separation and stagnation. In
1991, Stonebridge and Brophy68 detected spiral ﬂow in
peripheral arteries of the lower extremities and were
the ﬁrst to conclude that ﬂow in arteries may be spiral
in nature. Since that, the presence of spiral ﬂow in right
and left iliac and femoral arteries of healthy volunteers
has been conﬁrmed by several researchers using colour
Doppler and vector Doppler imaging.31,63,70 Spiral
ﬂow can be detected using colour Doppler ultrasound
with the transducer perpendicular to the vessel and
appears as a red–blue split (Fig. 1).31 Caro et al.7 used
phase contrast MRI to present rotating asymmetric
axial velocity proﬁles in iliac and carotid arteries. In
addition, the existence of rotational patterns distal
from the carotid bifurcation have been conﬁrmed with
both MRI and ultrasound imaging techniques.29,74
Maintenance of Spiral Flow in Arteries
The propagation of spiral ﬂow in the arterial system
is supported by its multi-planar, curvy, tapering and
branching geometry.7,24,70 Numerical simulations in
aortic arch models showed that a curved but planar
arch would exhibit a typical Dean ﬂow with two
symmetric opposite helical structures, instead of a
single spiral ﬂow which is the clinical observation,
indicating the importance of aortic torsion.52,53
Stonebridge and Brophy68 detected spiral folds on
arterial walls downstream from the aortic bifurcation
and postulated that such folds may support the prop-
agation of spiral ﬂow.
Clinical Correlation of Arterial Spiral Flow
Frazin et al.24 speculated that the tangential com-
ponent of the aortic blood ﬂow affects the wall shear
forces and endothelial cell alignment and may play an
important role in plaque deposition, organ perfusion,
dissection formation and ﬂow separation in aortic
branches. Numerical studies supported the hypothesis
that the aortic spiral ﬂow may enhance oxygen and
nutrient ﬂux to the arterial wall.52,58 Other computa-
tional53 and ex vivo19 studies showed that helical ﬂow
may suppress the luminal surface concentration polar-
isation of low-density lipoproteins, which is involved in
the localisation of atherogenesis. Zhan et al.82 pre-
sented that spiral ﬂow, in comparison to parabolic ﬂow,
decreased the adhesion of platelets in a test tube and
concluded that spiral ﬂow may decrease the risk of
acute thrombus formation in vascular implants. Their
results were supported by Massai et al.56 who showed
an inverse relationship between platelet activation and
helical ﬂow in a stenosed carotid model using CFD.
It is believed that the helical velocity of spiral ﬂow is
an important stabilising factor of WSS magnitude
and dispersion and therefore may have a beneﬁcial
eﬀect on the mechanisms of endothelial damage and
repair.7,24,70,72 Morbiducci et al.57 presented an inverse
relationship between OSI and helical ﬂow. They
hypothesised that helical ﬂow may damp WSS tem-
poral gradient in aortocoronary bypass. Chen et al.10
compared helical and parabolic ﬂow in a stented region
and found that helical ﬂow reduced the size of dis-
turbed ﬂow zones, increased the average WSS and
lowered the OSI, which could suppress the develop-
ment of restenosis after stent implantation. Caro et al.6
demonstrated that a helical blood pattern may protect
vessels from NIH and thrombosis because it introduces
uniform WSS, increases blood ﬂow mixing, and re-
duces ﬂow stagnation, separation and instability.
Other studies linked the arterial three-dimensionality
with reduction of low WSS regions and increase oxy-
gen ﬂux protecting the endothelium.16,17 Spiral ﬂow
was also compared with parabolic ﬂow in stenosed
straight tube models. The former ﬂow pattern was
associated with a signiﬁcant reduction of turbulent
kinetic energy and capability to preserve a coherent
pattern downstream of the stenosis, suggesting ﬂow
stabilisation even in stenosed vessels.61,69
FIGURE 1. Single spiral flow detected with colour Doppler
ultrasound; (a) femoral artery; (b) internal and external carotid
arteries.
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In a clinical study, Houston et al.35 linked the
reduction of systolic spiral ﬂow in the aortic arch with
carotid atheromatous disease. In a further clinical
study, they concluded that the lack of aortic spiral ﬂow
in patients with renal arterial stenosis is related with
signiﬁcant short-term renal function deterioration.34
It has been noted that spiral ﬂow may also have a
detrimental role in the cardiovascular system.28,68 For
instance, the spiral folds detected on arterial walls68
can be associated with helical distribution of low
WSS.7 The potential link between shear forces induced
by rotational ﬂow and plaque deposition was also
noted by Frazin et al.23 Paul and Larman61 applied
spiral and parabolic ﬂow in a stenosed numerical
model and found increased OSI for spiral ﬂow. Other
studies demonstrated that spiral ﬂow can increase
pressure drop and showed a proportional relationship
between pressure drop and helicity.10,15,44
In order to prove the exact correlation between
spiral ﬂow and atheromatous plagues, there is still a
need for long-term randomised clinical data where the
relationship between ﬂow patterns and development of
arterial disease will be characterised.59,67
INTRODUCTING FLOW OPTIMISATION TO
STENT DESIGN
Stent design plays an important role in development
of in-stent restenosis and downstream progression of
PAD after implantation. Stent struts denude most of
the endothelium in contact and re-endothelialisation is
required. The endothelial damage is increased in
the case of a balloon expanded stent, because of the
extensive contact between foreign materials and the
arterial wall.30,77 Arterial stress from stent deployment
does not only injure the endothelium but also stretches
the media and adventitia, which can disrupt the stent
incorporation process.22 If a stent is oversized medial
injury is possible, due to high stress against the wall,
initiating early thrombosis and acute inﬂammation.21
Local haemodynamics is another mechanism asso-
ciated with both in-stent restenosis and distal disease
progression, because a stent alters the haemodynamics
in both the stented region and downstream from it.
The presence of a stent in infrainguinal arteries induces
stagnation, recirculation zones, areas of low, high or
oscillatory WSS and prolonged particle residence time,
creating an unstable environment and disturbing the
physiologic spiral ﬂow.11,39,59,77 Wentzel et al.78
applied CFD in stented coronary arteries and showed
an inverse relationship between in-stent neointimal
thickness formation and WSS magnitude.
Haemodynamics are aﬀected by both stent oversiz-
ing and undersizing. Stent oversizing increases the lu-
men diameter and consequently reduces the blood ﬂow
velocity and WSS in the stented region. It also creates a
step-up phenomenon at the edges of the device devel-
oping recirculation zones. On the other side stent
undersizing may leave tiny gaps between the struts and
the arterial wall, which introduces ﬂow resistance and
increases WSS gradient and OSI in comparison to
FIGURE 2. Primary and secondary patency rates of above- and below-the-knee bypasses of spiral graft for PAD.71
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correct-sized cases.11,59 The patency of a stent is also
dependent on the pre-operative arterial geometry. For
example, stent revascularisation of a curvy artery
may cause arterial straightening. This would result
in arterial kinking at the edges of the stent, inducing
large spatial and temporal variations of WSS and
increased arterial trauma, supporting the development
of NIH.50,79
Stent design characteristics such as stent strut pat-
tern, struts spacing, thickness and roughness aﬀect
both arterial trauma and local haemodynamics. La-
Disa et al.51 found that a reduction of struts number,
thickness and width leaves a higher percentage of
arterial wall intact and elevates WSS. This reduction
would also decrease the extent of arterial trauma.
Jimenez and Davies39 proposed a streamlined stent
strut design in order to reduce recirculation zones and
therefore prevent thrombosis and support re-endothe-
lialisation.
Another important characteristic of infrainguinal
stents is their material properties and speciﬁcally their
ability to withstand movements and ﬂexions of the
arteries as a result of everyday activities of a patient.
The incidence of infrainguinal stent fracture ranges
between 2 and 65%. Stent fracture may cause further
haemodynamic disturbances and a new wall injury
leading to restenosis.18,22
FLOW MODIFICATION STENTS
Research on physiologic spiral ﬂow has motivated
two manufacturers to develop peripheral arterial stents
capable of generating spiral ﬂow. These devices aim to
re-introduce spiral ﬂow in order to reduce NIH and
progression of atherosclerosis, and therefore provide
improved stent and vessel patency rates for patients
with PAD.
Spiral Flow Stent
Results of research that spiral ﬂow may create a
stabilised, coherent and protective blood ﬂow ﬁeld, led
Vascular Flow Technologies Ltd. (VFT, Dundee,
United Kingdom), to develop Spiral FlowTM vascular
implants. Spiral ﬂow technology was originally applied
in prosthetic grafts for the treatment of PAD and for
arteriovenous dialysis conduits. These devices are
supported by an internal spiral inducer ridge in their
distal end in order to generate spiral blood ﬂow and
have received CE mark and FDA (Food and Drug
Administration) approval. In 2012, Stonebridge et al.71
presented a nonrandomised multicentre clinical study
on 39 patients who received spiral grafts for the
treatment of PAD. At 30 months the primary and
secondary patency rates were 81% for above-the-knee
bypasses and 57 and 64% respectively for below-the-
knee bypasses (Fig. 2). At the time of the publication
these patency rates were better or similar to other
FIGURE 3. Cross section velocity maps in the outflow
anastomosis of a spiral and a conventional graft for PAD,
tested under the same geometry and flow conditions in flow
phantoms. Velocity maps were estimated with CFD and de-
tected with vector Doppler ultrasound. (a, b) A dominant sin-
gle spiral with a second smaller spiral below (mainly seen in
the computational map). (c, d) Double spiral.44
FIGURE 4. (a) Spiral flow self-expanding stent prototype in-
serted in a testing tube. (b) Single spiral in the outflow of a
spiral stent implanted in a cadaveric model; steady flow was
used. (c–d) Single spiral and non-spiral flow in the outflow of
a spiral and a control stent respectively, positioned in a flow
phantom; steady flow was used. (e–f) Single spiral and non-
spiral flow in the outflow of a spiral and a control stent
respectively, implanted in porcine models; images were
obtained at peak systole. (g) Contrast angiogram of spiral
stent implanted in the right carotid artery of a pig; the red
arrow indicates a visible part of the spiral inducer and the
cross-section white line the ultrasound scan plane distal from
the outflow of the stent.
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relevant studies. Encouraging data were also presented
for the arteriovenous spiral graft in an animal38 and
two clinical studies.20,37 In the ﬁrst clinical study, In-
ston et al.37 veriﬁed the development of spiral ﬂow in
the distal anastomosis of a spiral graft and showed low
incidence of outﬂow stenosis and 75% primary pa-
tency at a mean time point of 188 days.37 In the second
clinical study, El-Sayed20 presented assisted primary
and secondary patency rates of 70 and 82% respec-
tively. These patency rates were signiﬁcantly better
than the historic data on conventional grafts in their
institution.20 The authors in both studies hypothesised
that these results were associated with the coherent
single spiral ﬂow in the venous graft anastomosis.
In addition, the spiral grafts were compared with
conventional grafts in idealised ﬂow phantom setups,
using experimental and computational approaches.44–46
A dominant single spiral was found in the distal
anastomosis of the spiral graft for PAD as well as a
second small ﬂow recirculation which was dissipated a
few centimetres downstream (Figs. 3a and 3b). On the
other hand a double spiral (Dean vortex) was found in
the distal anastomosis of the conventional graft
(Figs. 3c and 3d). The secondary ﬂow phenomena were
stronger for the spiral device as was seen by the greater
in-plane velocities (Fig. 3) and was veriﬁed comparing
the helicity in the outﬂow of the tested grafts.44 These
results showed that a spiral graft can reduce points of
ﬂow stagnation breaking the problematic symmetry of a
Dean vortex proﬁle which is observed in conventional
grafts,60,65 and introduce a stabilised ﬂow ﬁeld.
The re-introduction of naturally occurring spiral
arterial ﬂow in vascular grafts with improved clinical
results and long-term safety at 5 years post implanta-
tion, has led to development of an arterial spiral
inducing stent for the treatment of PAD. This device
FIGURE 5. Preclinical porcine study of carotid balloon expandable spiral stent compared to control stent. (a) Digital subtraction
angiogram post stent implantation with downstream cuffs. (b) Intima media ratio comparison of spiral versus control stent.
(c) Sample histology in four locations downstream from spiral and control stents shows increased neo-intimal hyperplasia in
control stent.33
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has a conventional cylindrical outside geometry,
where a part of the stent struts form a spiral
internal ridge, and it is covered with polytetraﬂuo-
roethylene (Fig. 4a). This spiral ridge is conﬁgured to
drive the blood in a spiral ﬂow pattern which is be-
lieved to protect the artery from restenosis and PAD
progression.
Such prototypes were housed in stent delivery sys-
tems and implanted in ultrasound ﬂow phantoms, pigs
(with approval by the Animal Experimentation Com-
mittee, Faculty of Medicine, Utrecht University, the
Netherlands and in accordance with the Netherlands
guidelines on animal care) and cadaveric models (eth-
ical approval was obtained from the University of
Dundee Thiel Advisory Group and the study was
complied with the Anatomy Act (Scotland) 2006). In
the ﬁrst two cases spiral stents were compared with
control stents of same dimensions and struts design.
Steady ﬂow was applied in the ﬂow phantoms and
cadaveric models. Spiral ﬂow was found in the outﬂow
of all spiral stents and non-spiral ﬂow pattern in the
outﬂow of the control stents as seen in Figs. 4b–4f.
Figure 4g shows a contrast-enhanced angiogram of a
spiral stent implanted in a porcine model and the
location of the ultrasound scan plane downstream
from the outﬂow of the stent. The current evaluation
of this device includes CFD simulations and longitu-
dinal histological studies in stenosed and non-stenosed
porcine models, as well as optimisation of the stent
struts design for increased durability and ﬂexibility.
In a previous similar spiral stent approach Houston
et al.33 incorporated a collapsible spiral induction form
made from medical grade polyurethane in 16 com-
mercially available balloon expandable stainless steel
stents. The spiral stents were remounted in delivery
systems and resterilised for implantation. These spiral
stents were compared with 16 control stents in carotid
porcine models. More speciﬁcally, a spiral and a con-
trol stent were implanted in the carotid arteries of 16
pigs. Two surgical cuffs were placed around each ar-
tery distal from the stented region as shown in Figs. 5a
and 5c, to analyse the progression of downstream
disease development for the spiral and control stents.
These cuffs created a minimum 50% stenosis (Fig. 5a).
Cross-section colour Doppler imaging was applied
distally from the stents to detect the ﬂow pattern
proﬁle. Histological analysis was carried out in the
locations shown in the diagram of Fig. 5c. Spiral ﬂow
was found in the outﬂow of spiral stents whereas dis-
turbed ﬂow was found in the outﬂow of control
devices. Histological analysis 45 days post-operatively
indicated signiﬁcantly reduced intima/media ratios and
reduced downstream neo-intimal thickening in spiral
versus control stents as shown in Figs. 5b and 5c
respectively.33
BioMimics 3D Vascular Biomimetric Stent
The BioMimics 3DTM vascular biomimetric stent
has been developed by Veryan Medical Ltd (West
Sussex, United Kingdom) for the treatment of super-
ﬁcial femoral and proximal popliteal arteries. This
device has a 3D helical shape (Fig. 6) in order to
maintain and propagate the physiologic helical ﬂow.
According to Veryan Medical the helical shape of the
BioMimics 3D stent decreases fracture incidents from
femoropopliteal arterial shortening during knee bend-
ing. It is claimed that the 3D helical geometry prevents
the stent from kinking and distributes the compressive
strain across the entire stent, in comparison to straight
stents which tend to kink creating high localised strain
regions. The BioMimics 3D stent has a tapered radial
stiffness at its ends, which aims to minimise the pos-
sibility of the step-up phenomenon, protecting from
ﬂow recirculation, stagnation and low WSS.76
A preliminary in vivo study of the BioMimics 3D
stent was based on porcine models (n = 10). Each
animal was implanted with a BioMimics 3D stent in
one carotid artery and a conventional stent in the other
one. The ability of the BioMimics 3D stent to create
FIGURE 6. BioMimics 3D helical stent (reproduced with
permission of Veryan Medical Ltd).76
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helical ﬂow was tested with colour Doppler imaging.
Histological cross-section tests at 1 month post-im-
plantation demonstrated a 45% reduction in NIH for
the helical device.66 The device received CE mark in
2012 and positive clinical data were recently presented
from a 2-year, multicentre, randomised study in 76
patients (Mimics study).81 50 of them received a
BioMimics 3D stent and the rest a control stent. The
primary patency at 2-years was 72% for the helical
stent and 55% for the control, showing a signiﬁcant
difference by log-rank test. No increase was detected in
the clinically driven target lesion revascularisation rate
for the BioMimics 3D stent between 12 and 24 months
in comparison to a threefold increase for the control
stent. The helical stent showed signiﬁcantly greater
curvature in comparison to the straight stent and a
correlation between primary patency and stent curva-
ture was hypothesised. No fracture was reported for
the BioMimics 3D stent.81
The BioMimics 3D has been developed based on
research by Caro who hypothesised the atheroprotec-
tive eﬀect of high WSS and showed that this is sup-
ported by blood helical ﬂow and arterial non-
planarity.5,7–9 Helical ﬂow technology was initially
applied in a small amplitude helical graft (Swirl-
GraftTM) for arteriovenous applications. This non-
planar graft was designed to introduce a single recir-
culation in its distal end-to-side anastomosis, instead of
a symmetric Dean vortex proﬁle which is observed in
the outﬂow of conventional grafts.60,65 The SwirlGraft
showed reduced thrombosis and NIH in a comparison
with conventional grafts in porcine models. The au-
thors used CFD data to link the superior in vivo results
of the SwirlGraft device with relatively uniform WSS,
increased in-plane mixing and inhibition of ﬂow sepa-
ration and stagnation.6 In a following non-randomised
6-month-long clinical study by Huijbregts et al.,36 the
helical graft was associated with promising primary
(58%), assisted primary (84%) and secondary (100%)
patency rates. At the time of publication these patency
rates were better or similar to other relevant studies.
However, thrombosis incidences exceeded the clinical
practice guidelines for vascular access at that time.
Angiographic examination suggested that there was a
reduction of helical geometry upon implantation and it
was hypothesised that this could be related to the
increased thrombosis incidences.
CONCLUSIONS
The key role of haemodynamics in arterial wall
function is well accepted. The importance of a better
understanding of physiologic blood ﬂow and its rele-
vance to optimised arterial stents in PAD is clear.
Current research indicates that re-introducing spiral
arterial blood ﬂow after the treatment of PAD, has
theoretical beneﬁts with the potential to reduce NIH,
thrombosis and disease progression. Spiral vascular
grafts show encouraging long-term clinical results
while initial preclinical and clinical results of ﬂow
modiﬁcation stents are promising. Such stent designs
may stabilise the arterial haemodynamics and there-
by may contribute to the improvement of clinical
outcomes for endovascular treatment of PAD.
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